SCHEMBL4521541

SCHEMBL4521541

Cc1cccc(C)c1C1CCN(Cc2c(-c3ccccc3)n(CC(=O)NC3CCN(C(=O)OC(C)(C)C)CC3)c3ccccc23)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
KMT2A Q03164 2/20 0.45
HSD17B10 Q99714 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 3/20 0.44
UBE2N P61088 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 3/20 0.41
THRB P10828 1/20 0.41
PNP P00491 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
BRD4 O60885 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
POLB P06746 2/20 0.39
USP2 O75604 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4522972 0.89 UBE2N (0.45) KDM4EKMT2AHSD17B10ALDH1A1UBE2N
SCHEMBL4518521 0.86 UBE2N (0.45) KDM4EKMT2AHSD17B10ALDH1A1UBE2N
SCHEMBL4514150 0.85 UBE2N (0.44) KDM4EKMT2AHSD17B10ALDH1A1UBE2N
SCHEMBL4529448 0.82 UBE2N (0.42) KDM4EKMT2AHSD17B10ALDH1A1UBE2N
SCHEMBL4519785 0.82 UBE2N (0.43) KDM4EKMT2AHSD17B10ALDH1A1UBE2N
SCHEMBL4514740 0.79 HTR2A (0.39) KDM4EKMT2AHSD17B10ALDH1A1UBE2N
SCHEMBL4520660 0.77 TSHR (0.49) KDM4EALDH1A1TP53POLBMAPK1
SCHEMBL4505706 0.76 S1PR5 (0.39) KDM4EALDH1A1CHRM2CHRM4CHRM1
Hydrochloric Acid SCHEMBL4516965 0.75 KDM4E (0.44) KDM4EKMT2AALDH1A1POLBMAPK1
SCHEMBL5421524 0.75 ALDH1A1 (0.42) HSD17B10ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor OGFRL1, OPRL1, ORMDL3 KDM4E 4525/4885KMT2A 3625/4885HSD17B10 2560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.